Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Birth Control
Sort By
Newest First
1 / 1
1 / 1
Innovation
FDA Releases Final Classification for Natural Cycles, the First and Only Birth Control App in the U.S.
Natural Cycles
PR-M03-19-NI-031
Mar 12, 2019
FDA Acceptance
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Developed by Exeltis
Exeltis
PR-M12-18-NI-030
Dec 10, 2018
FDA Approval
TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control
TherapeuticsMD, Inc.
PR-M09-18-NI-002
Sep 04, 2018
